Tianda Pharmaceuticals Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	86.38	85.69	162.44	340.28	334	234.98
Short-Term Investments	5.89	6.14	8.43	21.73	3.31	2.97
Trading Asset Securities	6.04	-	-	3.17	14.58	-
Cash & Short-Term Investments	98.3	91.83	170.87	365.17	351.9	237.96
Cash Growth	-5.27%	-46.26%	-53.21%	3.77%	47.88%	-24.05%
Accounts Receivable	58.41	77.42	104.8	138.75	141.74	145.21
Other Receivables	2.09	3.97	1.57	4.07	3.15	2.93
Receivables	60.5	81.39	106.38	142.82	144.89	148.14
Inventory	51.78	40.21	65.15	48.19	74.89	64.39
Prepaid Expenses	2.29	2.45	1.81	1.99	5.76	8.14
Other Current Assets	-	-	-	-	-	147.77
Total Current Assets	212.88	215.88	344.21	558.17	577.45	606.41
Property, Plant & Equipment	392.77	386.09	412.74	400.51	433.09	377.78
Long-Term Investments	-	-	9.22	0.74	1.77	6.87
Goodwill	93.06	90.39	95.23	95.95	106.21	103.27
Other Intangible Assets	62	27.21	1.31	1.75	15.51	19.56
Long-Term Deferred Charges	-	33.32	19.36	4.37	6.43	8.23
Other Long-Term Assets	14.1	12.14	35.22	26.97	23.7	11.35
Total Assets	774.8	765.02	917.29	1,088	1,164	1,133
Accounts Payable	97.86	77.82	117.99	80.73	110.11	91.54
Accrued Expenses	32.12	29.37	64.31	71.19	63.99	59.9
Current Portion of Long-Term Debt	80.63	122.07	96.49	64.67	57.26	18.89
Current Portion of Leases	4.3	2.19	5.68	5.63	4.6	4.18
Current Income Taxes Payable	0.43	0.75	3.74	3.72	4.24	3.73
Current Unearned Revenue	9.88	8.43	13.71	111.73	14.08	11.76
Other Current Liabilities	8.27	10.36	11.38	24.76	17.37	24.23
Total Current Liabilities	233.49	251	313.31	362.43	271.66	214.23
Long-Term Debt	44.28	-	8.36	61.97	90.63	110.8
Long-Term Leases	6.35	3.18	3.07	8.77	7.94	11.65
Long-Term Unearned Revenue	-	-	-	0.09	0.19	0.3
Long-Term Deferred Tax Liabilities	5.17	5.18	0.61	0.96	4.65	5.97
Total Liabilities	289.3	259.36	325.35	434.23	375.08	342.97
Common Stock	215	215	215	215	215	215
Additional Paid-In Capital	359.07	359.07	364.66	364.66	364.66	364.66
Retained Earnings	3.81	37.05	98.42	128.17	186.77	212.13
Comprehensive Income & Other	-91.95	-105.29	-86.02	-80	-9.68	-35.09
Total Common Equity	485.94	505.84	592.07	627.83	756.75	756.71
Minority Interest	-0.44	-0.17	-0.13	26.41	32.32	33.79
Shareholders' Equity	485.5	505.67	591.94	654.24	789.08	790.49
Total Liabilities & Equity	774.8	765.02	917.29	1,088	1,164	1,133
Total Debt	135.56	127.45	113.6	141.05	160.43	145.53
Net Cash (Debt)	-37.26	-35.61	57.28	224.12	191.47	92.43
Net Cash Growth	-	-	-74.44%	17.06%	107.15%	-67.92%
Net Cash Per Share	-0.02	-0.02	0.03	0.10	0.09	0.04
Filing Date Shares Outstanding	2,150	2,150	2,150	2,150	2,150	2,150
Total Common Shares Outstanding	2,150	2,150	2,150	2,150	2,150	2,150
Working Capital	-20.62	-35.12	30.9	195.75	305.79	392.18
Book Value Per Share	0.23	0.24	0.28	0.29	0.35	0.35
Tangible Book Value	330.89	388.24	495.53	530.13	635.03	633.88
Tangible Book Value Per Share	0.15	0.18	0.23	0.25	0.30	0.29
Buildings	-	242.08	228.71	229.42	249.16	32.18
Machinery	-	214.64	212.46	179.2	184.23	87.97
Construction In Progress	-	25.34	40.39	28.98	23.69	267.05
Leasehold Improvements	-	5.72	4.71	4.02	4.17	3.88

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.